In 2025, 6% of US adults are taking a GLP-1. But the popularity of weight-loss drugs isn’t the only thing changing the obesity care landscape. To share the state of the Obesity market in 2025, host Rachel (Rae) Woods invites Advisory Board experts Gaby Marmolejos and Madeline Vogel to share the latest on bariatric surgery volumes, coverage decisions, patient preferences, drug shortages, compounding, and the new competitive landscape for direct-to-consumer obesity care. Given the pace of change in just a few short years, Rae also invites her guests make predictions about the obesity market two years from now.
Read the full article: Drugs, Surgeries, and Shortages: The State of Obesity Care in 2025 //
Source: https://www.advisory.com/radio-advisory/248